AAAAAA

   
Results: 1-23 |
Results: 23
Issues in making a therapeutic choice: recombinant and/or human-derived products
Authors: Aledort, LM
Citation: Lm. Aledort, Issues in making a therapeutic choice: recombinant and/or human-derived products, HAEMOPHILIA, 7(1), 2001, pp. 89-90
Making a therapeutic choice: human versus recombinant fractions - can we do it?
Authors: Aledort, LM
Citation: Lm. Aledort, Making a therapeutic choice: human versus recombinant fractions - can we do it?, HAEMOPHILIA, 7, 2001, pp. 1-3
Therapeutic choices for patients with hemophilia and high-titer inhibitors
Authors: Kulkarni, R Aledort, LM Berntorp, E Brackman, HH Brown, D Cohen, AR Ewing, NP Gringeri, A Gruppo, R Hoots, K Leissenger, C Peerlinck, K Poon, MC Wong, WY
Citation: R. Kulkarni et al., Therapeutic choices for patients with hemophilia and high-titer inhibitors, AM J HEMAT, 67(4), 2001, pp. 240-246
Adverse reactions related to rVIIa?
Authors: Aledort, LM
Citation: Lm. Aledort, Adverse reactions related to rVIIa?, AM J HEMAT, 67(3), 2001, pp. 213-213
Definitions in hemophilia - Recommendation of the Scientific Subcommittee on factor VIII and factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Authors: White, GC Rosendaal, F Aledort, LM Lusher, JM Rothschild, C Ingerslev, J
Citation: Gc. White et al., Definitions in hemophilia - Recommendation of the Scientific Subcommittee on factor VIII and factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, THROMB HAEM, 85(3), 2001, pp. 560-560
Rebuttal to massive skin necrosis associated to the prothrombin gene G20210A mutation
Authors: Aledort, LM
Citation: Lm. Aledort, Rebuttal to massive skin necrosis associated to the prothrombin gene G20210A mutation, THROMB HAEM, 85(2), 2001, pp. 374-374
Leukemia after liver transplant
Authors: Doti, CA Gondolesi, GE Sheiner, PA Emre, S Miller, CM Aledort, LM
Citation: Ca. Doti et al., Leukemia after liver transplant, TRANSPLANT, 72(10), 2001, pp. 1643-1646
Hemophilia
Authors: Aledort, LM
Citation: Lm. Aledort, Hemophilia, N ENG J MED, 345(14), 2001, pp. 1066-1066
rFVIIa - Its thrombogenicity
Authors: Aledort, LM
Citation: Lm. Aledort, rFVIIa - Its thrombogenicity, THROMB HAEM, 84(3), 2000, pp. 522-523
Recombinant factor VIIa is a pan-hemostatic agent? (vol 83, pg 637, 2000)
Authors: Aledort, LM
Citation: Lm. Aledort, Recombinant factor VIIa is a pan-hemostatic agent? (vol 83, pg 637, 2000), THROMB HAEM, 84(3), 2000, pp. 523-523
Recombinant factor VIIa is a pan-hemostatic agent?
Authors: Aledort, LM
Citation: Lm. Aledort, Recombinant factor VIIa is a pan-hemostatic agent?, THROMB HAEM, 83(5), 2000, pp. 637-638
Inga Marie Nilsson, 1923-1999
Authors: Berntorp, E Dahlback, B Holmberg, L Aledort, LM
Citation: E. Berntorp et al., Inga Marie Nilsson, 1923-1999, THROMB HAEM, 83(1), 2000, pp. III-III
Economics of hemophilia care
Authors: Aledort, LM
Citation: Lm. Aledort, Economics of hemophilia care, HAEMOSTASIS, 30(6), 2000, pp. 333-336
Unexpected bleeding disorders: Identification, diagnosis and management - Proceedings of a Corporate Symposium. preceding the 41st annual meeting of the American Society of Hematology - New Orleans, USA - Introduction
Authors: Aledort, LM
Citation: Lm. Aledort, Unexpected bleeding disorders: Identification, diagnosis and management - Proceedings of a Corporate Symposium. preceding the 41st annual meeting of the American Society of Hematology - New Orleans, USA - Introduction, CLIN LAB H, 22, 2000, pp. 1-1
Obstetrical and gynaecological bleeding: a common presenting symptom
Authors: Kadir, RA Aledort, LM
Citation: Ra. Kadir et Lm. Aledort, Obstetrical and gynaecological bleeding: a common presenting symptom, CLIN LAB H, 22, 2000, pp. 12-16
Unexpected Bleeding Disorders: Identification, diagnosis and management - Proceedings of a Corporate Symposium. preceding the 41st Annual Meeting of the American Society of Hematology - New Orleans, USA - Panel discussion
Authors: Aledort, LM Teitel, JM Green, D Sahud, M Rice, I
Citation: Lm. Aledort et al., Unexpected Bleeding Disorders: Identification, diagnosis and management - Proceedings of a Corporate Symposium. preceding the 41st Annual Meeting of the American Society of Hematology - New Orleans, USA - Panel discussion, CLIN LAB H, 22, 2000, pp. 30-32
Immune tolerance induction: Is it cost effective? We know too little
Authors: Aledort, LM
Citation: Lm. Aledort, Immune tolerance induction: Is it cost effective? We know too little, SEM THROMB, 26(2), 2000, pp. 189
Immune tolerance in hemophilia and inhibitors: a cost analysis - Reply
Authors: Aledort, LM
Citation: Lm. Aledort, Immune tolerance in hemophilia and inhibitors: a cost analysis - Reply, TRANSFUSION, 40(4), 2000, pp. 496-496
Phenotypic expressions of CCR5-Delta 32/Delta 32 homozygosity
Authors: Nguyen, GT Carrington, M Beeler, JA Dean, M Aledort, LM Blatt, PM Cohen, AR DiMichele, D Eyster, ME Kessler, CM Konkle, B Leissinger, C Luban, N O'Brien, SJ Goedert, JJ O'Brien, TR
Citation: Gt. Nguyen et al., Phenotypic expressions of CCR5-Delta 32/Delta 32 homozygosity, J ACQ IMM D, 22(1), 1999, pp. 75-82
Economic aspects of haemophilia care
Authors: Aledort, LM
Citation: Lm. Aledort, Economic aspects of haemophilia care, HAEMOPHILIA, 5(6), 1999, pp. 373-373
Challenges in the treatment of haemophilia with inhibitors - Introduction
Authors: Aledort, LM
Citation: Lm. Aledort, Challenges in the treatment of haemophilia with inhibitors - Introduction, HAEMOPHILIA, 5, 1999, pp. IV-IV
Immune tolerance in hemophiliacs: Can we afford it? Is it worth it?
Authors: Aledort, LM
Citation: Lm. Aledort, Immune tolerance in hemophiliacs: Can we afford it? Is it worth it?, TRANSFUSION, 39(9), 1999, pp. 1034-1035
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
Authors: Key, NS Aledort, LM Beardsley, D Cooper, HA Davignon, G Ewenstein, BM Gilchrist, GS Gill, JC Glader, B Hoots, WK Kisker, CT Lusher, JM Rosenfield, CG Shapiro, AD Smith, H Taft, E
Citation: Ns. Key et al., Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors, THROMB HAEM, 80(6), 1998, pp. 912-918
Risultati: 1-23 |